Hydroxychloroquine for all patients with lupus nephritis: yes
Nephrology Dialysis Transplantation · 01.04.2025 · 40 (4) · 610-613
DOI: 10.1093/ndt/gfae280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 27.11.2024. Verfasst von Maria Pappa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Fourth Department of Internal Medicine, National and Kapodistrian University of Athens, "Attikon" University Hospital, Athens, Gre…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Rheumatology Unit, Fourth Department of Internal Medicine, National and Kapodistrian University of Athens, "Attikon" University Hospital, Athens, Greece.
- Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece.
ORCID-Profile: Maria Pappa, Antonis Fanouriakis
Zitieren
APA
Pappa, M., Boumpas, D. T., & Fanouriakis, A. (2025). Hydroxychloroquine for all patients with lupus nephritis: yes. Nephrology Dialysis Transplantation, 40(4), 610-613. https://doi.org/10.1093/ndt/gfae280
Vancouver
Pappa M, Boumpas DT, Fanouriakis A. Hydroxychloroquine for all patients with lupus nephritis: yes. Nephrology Dialysis Transplantation. 2025;40(4):610-613. doi:10.1093/ndt/gfae280
BibTeX
@article{Pappa2025,
author = {Pappa, Maria and Boumpas, Dimitrios T and Fanouriakis, Antonis},
title = {Hydroxychloroquine for all patients with lupus nephritis: yes},
journal = {Nephrology Dialysis Transplantation},
year = {2025},
volume = {40},
number = {4},
pages = {610--613},
doi = {10.1093/ndt/gfae280}
}
EUVIMED